-
Record quarterly revenue of
$173 million , up 15% YoY, exceeding outlook - Non-insurance revenue up 34% YoY and was 58% of total revenue
-
Adjusted EBITDA of
$9 million , up 30% YoY, exceeding outlook - Strong balance sheet with no bank debt
For the fiscal third quarter, the Company reported revenue of
GAAP net loss for the fiscal third quarter was
Adjusted EBITDA for the fiscal third quarter was
“Fiscal Q3 results were strong,” commented
“Turning to our outlook, we expect continued strong growth in non-insurance client verticals in FYQ4, and beyond. We expect auto insurance revenue to decline sequentially in FYQ4, as carriers are unexpectedly pausing to assess the results of the recent surge, and to continue to adjust to complex market conditions. The long arc of auto insurance spending is still up and to the right. Carriers will continue to adjust and adapt, and marketing budgets will continue to shift from offline to online. Most consumers shop the digital channel, and performance marketing, pioneered and enabled by
“For full fiscal year 2023, which ends in June, we expect revenue of
“Our longer-term outlook has never been better. We expect double-digit annual revenue growth rates, on average, in coming years, due to continued strong performance in non-insurance businesses alone. We expect auto insurance revenue to be up and to the right, eventually returning to and exceeding FY2021 levels. We expect adjusted EBITDA to grow faster than revenue, eventually exceeding a 10% margin. Our adjusted EBITDA margin in March jumped to 7%, just from the early stages of the return of auto insurance revenue, demonstrating the leverage we expect in future quarters and years,” concluded Valenti.
Conference Call Today at
The Company will host a conference call and corresponding live webcast at
About
Non-GAAP Financial Measures and Definitions of Client Verticals
This release and the accompanying tables include a discussion of adjusted EBITDA, adjusted net income, adjusted diluted net income per share and free cash flow and normalized free cash flow, all of which are non-GAAP financial measures that are provided as a complement to results provided in accordance with accounting principles generally accepted in
We believe adjusted EBITDA, adjusted net income and adjusted diluted net income per share are relevant and useful information because they provide us and investors with additional measurements to analyze the Company's operating performance.
Adjusted EBITDA is useful to us and investors because (i) we seek to manage our business to a level of adjusted EBITDA as a percentage of net revenue, (ii) it is used internally by us for planning purposes, including preparation of internal budgets; to allocate resources; to evaluate the effectiveness of operational strategies and capital expenditures as well as the capacity to service debt, (iii) it is a key basis upon which we assess our operating performance, (iv) it is one of the primary metrics investors use in evaluating Internet marketing companies, (v) it is a factor in determining compensation, (vi) it is an element of certain financial covenants under our historical borrowing arrangements, and (vii) it is a factor that assists investors in the analysis of ongoing operating trends. In addition, we believe adjusted EBITDA and similar measures are widely used by investors, securities analysts, ratings agencies and other interested parties in our industry as a measure of financial performance, debt-service capabilities and as a metric for analyzing company valuations.
We use adjusted EBITDA as a key performance measure because we believe it facilitates operating performance comparisons from period to period by excluding potential differences caused by variations in capital structures (affecting interest expense), tax positions (such as the impact of changes in effective tax rates or fluctuations in permanent differences or discrete quarterly items), non-recurring charges, certain other items that we do not believe are indicative of core operating activities (such as litigation settlement expense, tax settlement expense, acquisition and divestiture costs, contingent consideration adjustment, restructuring costs and other income and expense) and the non-cash impact of depreciation expense, amortization expense and stock-based compensation expense.
With respect to our adjusted EBITDA guidance, the Company is not able to provide a quantitative reconciliation without unreasonable efforts to the most directly comparable GAAP financial measure due to the high variability, complexity and low visibility with respect to certain items such as taxes, and income and expense from changes in fair value of contingent consideration from acquisitions. We expect the variability of these items to have a potentially unpredictable and potentially significant impact on future GAAP financial results, and, as such, we also believe that any reconciliations provided would imply a degree of precision that would be confusing or misleading to investors.
Adjusted net income and adjusted diluted net income per share are useful to us and investors because they present an additional measurement of our financial performance, taking into account depreciation, which we believe is an ongoing cost of doing business, but excluding the impact of certain non-cash expenses (stock-based compensation, amortization of intangible assets, and contingent consideration adjustment), non-recurring charges and certain other items that we do not believe are indicative of core operating activities. We believe that analysts and investors use adjusted net income and adjusted diluted net income per share as supplemental measures to evaluate the overall operating performance of companies in our industry.
Free cash flow is useful to investors and us because it represents the cash that our business generates from operations, before taking into account cash movements that are non-operational, and is a metric commonly used in our industry to understand the underlying cash generating capacity of a company’s financial model. Normalized free cash flow is useful as it removes the fluctuations in operating assets and liabilities that occur in any given quarter due to the timing of payments and cash receipts and therefore helps investors understand the underlying cash flow of the business as a quarterly metric and the cash flow generation potential of the business model. We believe that analysts and investors use free cash flow multiples as a metric for analyzing company valuations in our industry.
We intend to provide these non-GAAP financial measures as part of our future earnings discussions and, therefore, the inclusion of these non-GAAP financial measures will provide consistency in our financial reporting. A reconciliation of these non-GAAP measures to GAAP is provided in the accompanying tables.
Legal Notice Regarding Forward Looking Statements
This press release and its attachments contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that involve risks and uncertainties. Words such as "estimate", "will”, "believe", “expect”, "intend", “outlook”, "potential", “promises” and similar expressions are intended to identify forward-looking statements. These forward-looking statements include the statements in quotations from management in this press release, as well as any statements regarding the Company's anticipated financial results, growth and strategic and operational plans. The Company's actual results may differ materially from those anticipated in these forward-looking statements. Factors that may contribute to such differences include, but are not limited to: the Company’s ability to maintain and increase client marketing spend; the Company's ability, whether within or outside the Company’s control, to maintain and increase the number of visitors to its websites and to convert those visitors and those to its third-party publishers' websites into client prospects in a cost-effective manner; the Company's exposure to data privacy and security risks; the impact from risks and uncertainties relating to the COVID-19 pandemic and its aftermath; the impact of changes in industry standards and government regulation including, but not limited to investigation enforcement activities or regulatory activity by the
|
|
||||||||
|
|
|
|
|
|
|
|
||
|
|
|
2023 |
|
|
2022 |
|
||
|
Assets |
|
|
|
|
|
|
||
|
Current assets: |
|
|
|
|
|
|
||
|
Cash and cash equivalents |
|
$ |
62,962 |
|
|
$ |
96,439 |
|
|
Accounts receivable, net |
|
|
105,606 |
|
|
|
81,429 |
|
|
Prepaid expenses and other assets |
|
|
8,729 |
|
|
|
4,924 |
|
|
Total current assets |
|
|
177,297 |
|
|
|
182,792 |
|
|
Property and equipment, net |
|
|
15,143 |
|
|
|
9,311 |
|
|
Operating lease right-of-use assets |
|
|
4,020 |
|
|
|
6,801 |
|
|
|
|
|
121,141 |
|
|
|
121,141 |
|
|
Other intangible assets, net |
|
|
41,362 |
|
|
|
49,696 |
|
|
Deferred tax assets, noncurrent |
|
|
47,547 |
|
|
|
44,220 |
|
|
Other assets, noncurrent |
|
|
5,969 |
|
|
|
5,948 |
|
|
Total assets |
|
$ |
412,479 |
|
|
$ |
419,909 |
|
|
Liabilities and Stockholders' Equity |
|
|
|
|
|
|
||
|
Current liabilities: |
|
|
|
|
|
|
||
|
Accounts payable |
|
$ |
41,279 |
|
|
$ |
42,410 |
|
|
Accrued liabilities |
|
|
62,892 |
|
|
|
54,459 |
|
|
Deferred revenue |
|
|
— |
|
|
|
341 |
|
|
Other liabilities |
|
|
8,622 |
|
|
|
12,369 |
|
|
Total current liabilities |
|
|
112,793 |
|
|
|
109,579 |
|
|
Operating lease liabilities, noncurrent |
|
|
1,291 |
|
|
|
3,858 |
|
|
Other liabilities, noncurrent |
|
|
13,868 |
|
|
|
20,472 |
|
|
Total liabilities |
|
|
127,952 |
|
|
|
133,909 |
|
|
Stockholders' equity: |
|
|
|
|
|
|
||
|
Common stock |
|
|
54 |
|
|
|
53 |
|
|
Additional paid-in capital |
|
|
327,929 |
|
|
|
316,422 |
|
|
Accumulated other comprehensive loss |
|
|
(267 |
) |
|
|
(261 |
) |
|
Accumulated deficit |
|
|
(43,189 |
) |
|
|
(30,214 |
) |
|
Total stockholders' equity |
|
|
284,527 |
|
|
|
286,000 |
|
|
Total liabilities and stockholders' equity |
|
$ |
412,479 |
|
|
$ |
419,909 |
|
|
|
||||||||||||||||
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
|
|
|
|
|
|
||||||||||
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
||||
|
Net revenue |
|
$ |
172,671 |
|
|
$ |
150,658 |
|
|
$ |
450,312 |
|
|
$ |
435,597 |
|
|
Cost of revenue (1) |
|
|
155,633 |
|
|
|
136,567 |
|
|
|
412,388 |
|
|
|
393,626 |
|
|
Gross profit |
|
|
17,038 |
|
|
|
14,091 |
|
|
|
37,924 |
|
|
|
41,971 |
|
|
Operating expenses: (1) |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Product development |
|
|
7,832 |
|
|
|
5,509 |
|
|
|
21,832 |
|
|
|
14,995 |
|
|
Sales and marketing |
|
|
3,385 |
|
|
|
2,033 |
|
|
|
9,651 |
|
|
|
7,773 |
|
|
General and administrative |
|
|
7,230 |
|
|
|
5,489 |
|
|
|
21,919 |
|
|
|
21,758 |
|
|
Operating (loss) income |
|
|
(1,409 |
) |
|
|
1,060 |
|
|
|
(15,478 |
) |
|
|
(2,555 |
) |
|
Interest income |
|
|
46 |
|
|
|
7 |
|
|
|
65 |
|
|
|
7 |
|
|
Interest expense |
|
|
(187 |
) |
|
|
(277 |
) |
|
|
(626 |
) |
|
|
(817 |
) |
|
Other (expense) income, net |
|
|
(12 |
) |
|
|
45 |
|
|
|
(44 |
) |
|
|
51 |
|
|
(Loss) income before income taxes |
|
|
(1,562 |
) |
|
|
835 |
|
|
|
(16,083 |
) |
|
|
(3,314 |
) |
|
Benefit from income taxes |
|
|
1,083 |
|
|
|
1,395 |
|
|
|
3,108 |
|
|
|
3,009 |
|
|
Net (loss) income |
|
$ |
(479 |
) |
|
$ |
2,230 |
|
|
$ |
(12,975 |
) |
|
$ |
(305 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Net (loss) income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Basic |
|
$ |
(0.01 |
) |
|
$ |
0.04 |
|
|
$ |
(0.24 |
) |
|
$ |
(0.01 |
) |
|
Diluted |
|
$ |
(0.01 |
) |
|
$ |
0.04 |
|
|
$ |
(0.24 |
) |
|
$ |
(0.01 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Weighted-average shares used in computing net (loss) income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Basic |
|
|
53,950 |
|
|
|
54,645 |
|
|
|
53,668 |
|
|
|
54,339 |
|
|
Diluted |
|
|
53,950 |
|
|
|
55,536 |
|
|
|
53,668 |
|
|
|
54,339 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
(1) Cost of revenue and operating expenses include stock-based compensation expense as follows: |
|
|||||||||||||||
|
Cost of revenue |
|
$ |
2,006 |
|
|
$ |
491 |
|
|
$ |
6,238 |
|
|
$ |
4,579 |
|
|
Product development |
|
|
695 |
|
|
|
203 |
|
|
|
2,225 |
|
|
|
1,497 |
|
|
Sales and marketing |
|
|
660 |
|
|
|
18 |
|
|
|
1,970 |
|
|
|
1,477 |
|
|
General and administrative |
|
|
1,947 |
|
|
|
699 |
|
|
|
5,622 |
|
|
|
4,337 |
|
|
|
||||||||||||||||
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
|
|
|
|
|
|
||||||||||
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
||||
|
Cash Flows from Operating Activities |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Net (loss) income |
|
$ |
(479 |
) |
|
$ |
2,230 |
|
|
$ |
(12,975 |
) |
|
$ |
(305 |
) |
|
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Depreciation and amortization |
|
|
4,972 |
|
|
|
4,247 |
|
|
|
14,004 |
|
|
|
12,660 |
|
|
Provision for sales returns and doubtful accounts receivable |
|
|
169 |
|
|
|
(31 |
) |
|
|
898 |
|
|
|
379 |
|
|
Stock-based compensation |
|
|
5,308 |
|
|
|
1,411 |
|
|
|
16,055 |
|
|
|
11,890 |
|
|
Change in the fair value of contingent consideration |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,698 |
|
|
Non-cash lease expense |
|
|
(280 |
) |
|
|
(272 |
) |
|
|
(822 |
) |
|
|
(752 |
) |
|
Deferred income taxes |
|
|
(981 |
) |
|
|
(1,204 |
) |
|
|
(3,260 |
) |
|
|
(2,819 |
) |
|
Other adjustments, net |
|
|
(6 |
) |
|
|
123 |
|
|
|
(147 |
) |
|
|
356 |
|
|
Changes in assets and liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Accounts receivable |
|
|
(34,363 |
) |
|
|
(13,574 |
) |
|
|
(25,075 |
) |
|
|
9,770 |
|
|
Prepaid expenses and other assets |
|
|
(3,238 |
) |
|
|
(473 |
) |
|
|
(3,826 |
) |
|
|
685 |
|
|
Accounts payable |
|
|
3,113 |
|
|
|
1,463 |
|
|
|
(1,562 |
) |
|
|
(5,448 |
) |
|
Accrued liabilities |
|
|
16,465 |
|
|
|
7,326 |
|
|
|
10,920 |
|
|
|
(8,184 |
) |
|
Deferred revenue |
|
|
(10 |
) |
|
|
48 |
|
|
|
(341 |
) |
|
|
51 |
|
|
Net cash (used in) provided by operating activities |
|
|
(9,330 |
) |
|
|
1,294 |
|
|
|
(6,131 |
) |
|
|
20,981 |
|
|
Cash Flows from Investing Activities |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Capital expenditures |
|
|
(485 |
) |
|
|
(1,656 |
) |
|
|
(2,038 |
) |
|
|
(2,376 |
) |
|
Internal software development costs |
|
|
(3,031 |
) |
|
|
(1,225 |
) |
|
|
(8,496 |
) |
|
|
(3,484 |
) |
|
Business acquisitions, net of cash acquired |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,000 |
) |
|
Other investing activities |
|
|
— |
|
|
|
85 |
|
|
|
(120 |
) |
|
|
85 |
|
|
Net cash used in investing activities |
|
|
(3,516 |
) |
|
|
(2,796 |
) |
|
|
(10,654 |
) |
|
|
(6,775 |
) |
|
Cash Flows from Financing Activities |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan |
|
|
1,409 |
|
|
|
229 |
|
|
|
3,206 |
|
|
|
1,273 |
|
|
Payment of withholding taxes related to release of restricted stock, net of share settlement |
|
|
(1,518 |
) |
|
|
(1,065 |
) |
|
|
(4,744 |
) |
|
|
(6,566 |
) |
|
Post-closing payments and contingent consideration related to acquisitions |
|
|
(3,184 |
) |
|
|
(3,239 |
) |
|
|
(10,408 |
) |
|
|
(9,759 |
) |
|
Repurchase of common stock |
|
|
— |
|
|
|
— |
|
|
|
(4,731 |
) |
|
|
— |
|
|
Net cash used in financing activities |
|
|
(3,293 |
) |
|
|
(4,075 |
) |
|
|
(16,677 |
) |
|
|
(15,052 |
) |
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
|
(2 |
) |
|
|
5 |
|
|
|
(14 |
) |
|
|
(9 |
) |
|
Net decrease in cash, cash equivalents and restricted cash |
|
|
(16,141 |
) |
|
|
(5,572 |
) |
|
|
(33,476 |
) |
|
|
(855 |
) |
|
Cash, cash equivalents and restricted cash at beginning of period |
|
|
79,118 |
|
|
|
115,050 |
|
|
|
96,453 |
|
|
|
110,333 |
|
|
Cash, cash equivalents and restricted cash at end of period |
|
$ |
62,977 |
|
|
$ |
109,478 |
|
|
$ |
62,977 |
|
|
$ |
109,478 |
|
|
Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Cash and cash equivalents |
|
$ |
62,962 |
|
|
$ |
109,463 |
|
|
$ |
62,962 |
|
|
$ |
109,463 |
|
|
Restricted cash included in other assets, noncurrent |
|
|
15 |
|
|
|
15 |
|
|
|
15 |
|
|
|
15 |
|
|
Total cash, cash equivalents and restricted cash |
|
$ |
62,977 |
|
|
$ |
109,478 |
|
|
$ |
62,977 |
|
|
$ |
109,478 |
|
|
|
||||||||||||||||
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
|
|
|
|
|
|
||||||||||
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
||||
|
Net (loss) income |
|
$ |
(479 |
) |
|
$ |
2,230 |
|
|
$ |
(12,975 |
) |
|
$ |
(305 |
) |
|
Amortization of intangible assets |
|
|
2,808 |
|
|
|
2,820 |
|
|
|
8,454 |
|
|
|
8,773 |
|
|
Stock-based compensation |
|
|
5,308 |
|
|
|
1,411 |
|
|
|
16,055 |
|
|
|
11,890 |
|
|
Acquisition and divestiture costs |
|
|
— |
|
|
|
51 |
|
|
|
32 |
|
|
|
516 |
|
|
Contingent consideration adjustment |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,698 |
|
|
Litigation settlement expense |
|
|
6 |
|
|
|
— |
|
|
|
6 |
|
|
|
— |
|
|
Tax settlement expense |
|
|
— |
|
|
|
— |
|
|
|
39 |
|
|
|
516 |
|
|
Restructuring costs |
|
|
102 |
|
|
|
122 |
|
|
|
183 |
|
|
|
222 |
|
|
Tax impact of non-GAAP items |
|
|
(1,597 |
) |
|
|
(1,738 |
) |
|
|
(4,012 |
) |
|
|
(6,776 |
) |
|
Adjusted net income |
|
$ |
6,148 |
|
|
$ |
4,896 |
|
|
$ |
7,782 |
|
|
$ |
17,534 |
|
|
Adjusted diluted net income per share |
|
$ |
0.11 |
|
|
$ |
0.09 |
|
|
$ |
0.14 |
|
|
$ |
0.31 |
|
|
Weighted average shares used in computing adjusted diluted net income per share |
|
|
55,680 |
|
|
|
55,536 |
|
|
|
54,952 |
|
|
|
55,665 |
|
|
|
||||||||||||||||
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
|
|
|
|
|
|
||||||||||
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
||||
|
Net (loss) income |
|
$ |
(479 |
) |
|
$ |
2,230 |
|
|
$ |
(12,975 |
) |
|
$ |
(305 |
) |
|
Interest and other expense, net |
|
|
153 |
|
|
|
225 |
|
|
|
605 |
|
|
|
759 |
|
|
Benefit from income taxes |
|
|
(1,083 |
) |
|
|
(1,395 |
) |
|
|
(3,108 |
) |
|
|
(3,009 |
) |
|
Depreciation and amortization |
|
|
4,972 |
|
|
|
4,247 |
|
|
|
14,004 |
|
|
|
12,660 |
|
|
Stock-based compensation |
|
|
5,308 |
|
|
|
1,411 |
|
|
|
16,055 |
|
|
|
11,890 |
|
|
Acquisition and divestiture costs |
|
|
— |
|
|
|
51 |
|
|
|
32 |
|
|
|
516 |
|
|
Contingent consideration adjustment |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,698 |
|
|
Litigation settlement expense |
|
|
6 |
|
|
|
— |
|
|
|
6 |
|
|
|
— |
|
|
Tax settlement expense |
|
|
— |
|
|
|
— |
|
|
|
39 |
|
|
|
516 |
|
|
Restructuring costs |
|
|
102 |
|
|
|
122 |
|
|
|
183 |
|
|
|
222 |
|
|
Adjusted EBITDA |
|
$ |
8,979 |
|
|
$ |
6,891 |
|
|
$ |
14,841 |
|
|
$ |
25,947 |
|
|
|
||||||||||||||||
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
|
|
|
|
|
|
||||||||||
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
||||
|
Net cash (used in) provided by operating activities |
|
$ |
(9,330 |
) |
|
$ |
1,294 |
|
|
$ |
(6,131 |
) |
|
$ |
20,981 |
|
|
Capital expenditures |
|
|
(485 |
) |
|
|
(1,656 |
) |
|
|
(2,038 |
) |
|
|
(2,376 |
) |
|
Internal software development costs |
|
|
(3,031 |
) |
|
|
(1,225 |
) |
|
|
(8,496 |
) |
|
|
(3,484 |
) |
|
Free cash flow |
|
|
(12,846 |
) |
|
|
(1,587 |
) |
|
|
(16,665 |
) |
|
|
15,121 |
|
|
Changes in operating assets and liabilities |
|
|
18,032 |
|
|
|
5,210 |
|
|
|
19,884 |
|
|
|
3,126 |
|
|
Normalized free cash flow |
|
$ |
5,186 |
|
|
$ |
3,623 |
|
|
$ |
3,219 |
|
|
$ |
18,247 |
|
|
|
||||||||||||||||
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
|
|
|
|
|
|
||||||||||
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
||||
|
Net revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Financial Services |
|
$ |
120,219 |
|
|
$ |
108,277 |
|
|
$ |
304,520 |
|
|
$ |
316,347 |
|
|
Home Services |
|
|
50,289 |
|
|
|
40,704 |
|
|
|
139,997 |
|
|
|
114,510 |
|
|
Other Revenue |
|
|
2,163 |
|
|
|
1,677 |
|
|
|
5,795 |
|
|
|
4,740 |
|
|
Total net revenue |
|
$ |
172,671 |
|
|
$ |
150,658 |
|
|
$ |
450,312 |
|
|
$ |
435,597 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20230503005749/en/
Investor Contact:
(347) 223-1682
ramparo@quinstreet.com
Source: